Syed H, Penner T, Mason A
Viruses. 2022; 14(9).
PMID: 36146750
PMC: 9502388.
DOI: 10.3390/v14091941.
Perez A, de Meis J, Rodriguez-Galan M, Savino W
Front Immunol. 2020; 11:1838.
PMID: 32983098
PMC: 7492291.
DOI: 10.3389/fimmu.2020.01838.
Hsu K, Lee Y, Chew A, Chiu S, Lim D, Greenhalgh D
Biochim Biophys Acta Mol Basis Dis. 2016; 1863(10 Pt B):2594-2600.
PMID: 27816520
PMC: 5415441.
DOI: 10.1016/j.bbadis.2016.10.026.
Lin X, Tang L, Yang J, Xu W
Biochim Biophys Acta. 2016; 1863(11):2594-2603.
PMID: 27469241
DOI: 10.1016/j.bbamcr.2016.07.007.
Lytvyak E, Montano-Loza A, Mason A
World J Gastroenterol. 2016; 22(1):349-60.
PMID: 26755881
PMC: 4698497.
DOI: 10.3748/wjg.v22.i1.349.
Cross-packaging of genetically distinct mouse and primate retroviral RNAs.
Al Dhaheri N, Phillip P, Ghazawi A, Ali J, Beebi E, Jaballah S
Retrovirology. 2009; 6:66.
PMID: 19602292
PMC: 2723071.
DOI: 10.1186/1742-4690-6-66.
Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter.
Etkind P, Stewart A, Wiernik P
Infect Agent Cancer. 2008; 3:2.
PMID: 18307792
PMC: 2277433.
DOI: 10.1186/1750-9378-3-2.
Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens.
Bhadra S, Lozano M, Payne S, Dudley J
PLoS Pathog. 2006; 2(12):e128.
PMID: 17140288
PMC: 1665650.
DOI: 10.1371/journal.ppat.0020128.
A novel method for modification of tumor cells with bacterial superantigen with a heterobifunctional cross-linking agent in immunotherapy of cancer.
Shimizu M, Matsuzawa A, Takeda Y
Mol Biotechnol. 2003; 25(1):89-94.
PMID: 13679639
DOI: 10.1385/MB:25:1:89.
Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.
Purdy A, Case L, Duvall M, Overstrom-Coleman M, Monnier N, Chervonsky A
J Exp Med. 2003; 197(2):233-43.
PMID: 12538662
PMC: 2193815.
DOI: 10.1084/jem.20021499.
Neutralizing antiviral antibody responses.
Zinkernagel R, Lamarre A, Ciurea A, Hunziker L, Ochsenbein A, McCoy K
Adv Immunol. 2001; 79:1-53.
PMID: 11680006
PMC: 7130890.
DOI: 10.1016/s0065-2776(01)79001-3.
Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity.
Lapatschek M, Durr S, Lower R, Magin C, Wagner H, Miethke T
J Virol. 2000; 74(14):6386-93.
PMID: 10864649
PMC: 112145.
DOI: 10.1128/jvi.74.14.6386-6393.2000.
Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.
Mu H, Sawitzke A, Cole B
Infect Immun. 2000; 68(3):1142-9.
PMID: 10678918
PMC: 97259.
DOI: 10.1128/IAI.68.3.1142-1149.2000.
Autospecific gammadelta thymocytes that escape negative selection find sanctuary in the intestine.
Lin T, Yoshida H, Matsuzaki G, Guehler S, Nomoto K, Barrett T
J Clin Invest. 1999; 104(9):1297-305.
PMID: 10545528
PMC: 481085.
DOI: 10.1172/JCI7437.
T-cell receptor Vbeta gene expression in experimental lupus nephritis.
Sutmuller M, Baelde H, Ouellette S, de Heer E, Bruijn J
Immunology. 1998; 95(1):18-25.
PMID: 9767452
PMC: 1364371.
DOI: 10.1046/j.1365-2567.1998.00565.x.
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.
Wekerle T, Sayegh M, Hill J, Zhao Y, Chandraker A, SWENSON K
J Exp Med. 1998; 187(12):2037-44.
PMID: 9625763
PMC: 2212372.
DOI: 10.1084/jem.187.12.2037.
Superantigens in insulin-dependent diabetes mellitus.
Luppi P, Trucco M
Springer Semin Immunopathol. 1996; 17(4):333-62.
PMID: 8966660
DOI: 10.1007/BF01795133.
Superantigen related to rabies.
Lafon M, Galelli A
Springer Semin Immunopathol. 1996; 17(4):307-18.
PMID: 8966658
DOI: 10.1007/BF01795131.
The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens.
Cole B, Knudtson K, Oliphant A, Sawitzke A, Pole A, Manohar M
J Exp Med. 1996; 183(3):1105-10.
PMID: 8642252
PMC: 2192318.
DOI: 10.1084/jem.183.3.1105.
Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
Cameron E, Campbell M, Blyth K, Argyle S, Keanie L, Neil J
Br J Cancer. 1996; 73(1):13-7.
PMID: 8554976
PMC: 2074291.
DOI: 10.1038/bjc.1996.3.